Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

CYTO Altamira Therapeutics Ltd

1,61

-0,01 (-0,62%)

Zuletzt aktualisiert: 20:36:01

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Altamira Therapeutics (NASDAQ:CYTO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Altamira Therapeutics Charts.

Altamira Therapeutics (NASDAQ:CYTO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Altamira Therapeutics Charts.

News Altamira Therapeutics Ltd

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
Mittwoch 1 Mai 2024 (1 Tag vor) • GlobeNewswire Inc.

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
Mittwoch 24 April 2024 (1 Woche vor) • GlobeNewswire Inc.

Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
Mittwoch 10 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
Donnerstag 4 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
Montag 25 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal
Mittwoch 7 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
Mittwoch 24 Januar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 424B4 - Prospectus [Rule 424(b)(4)]
Montag 22 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Montag 22 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 19 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 19 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 19 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Altamira Therapeutics Ltd News-Artikel

Invesco QQQ Trust Series 1

Euro vs US Dollar

Energy Select Sector SPDR

Financial Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen